OCULAR THERAPEUTIX, INC - 10-Q Filing
Ocular Therapeutix reports Q3 2026 financial results with significant derivative liability and customer concentration disclosures.
Tickers: $OCUL
Read the full article at SEC EDGAR
Part of the story Minerva Neurosciences, Inc. - 10-Q Filing (3 articles)